Breaking
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
Read full story on The New York Times →
Global — Gina Kolata and Rebecca Robbins
In a key clinical trial, patients who got the pill, daraxonrasib, lived twice as long as those who got chemotherapy.
This report is published with credit to The New York Times. The wire sent a summary; open the original for any extra context. Read on The New York Times →
Source: The New York Times · Gina Kolata and Rebecca Robbins. Published 26 Aug 2026, 03:23 pm.
Most relevant
Higher revenue and employee limits for small businesses that get federal contracts and loans could disadvantage the smallest companies, their owners say.
Read on The New York Times →Editor’s choice
The cost of the fuel, used in farm machinery, trucks and other heavy equipment, has surged because of the war in Iran and Ukrainian attacks on Russian refineries.
Read on The New York Times →Also developing
The social media giant settled with 47 states, the District of Columbia and U.S. territories, and agreed to make major changes to its products over claims its platforms endangered children.
Read on The New York Times →